2026 ICD-10-CM Diagnosis Code D47.4Osteomyelofibrosis
ICD-10-CM Codes›C00–D49›D37-D48›D47
- Billable — Valid for Submission
- Not Chronic
D47.4 is a billable ICD-10-CM diagnosis code for osteomyelofibrosis. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 814 through 816. Coders also document this condition as myelofibrosis. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Neoplasms of unspecified nature or uncertain behavior.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Myelofibrosis
- Primary myelofibrosis
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Inclusion Terms
- Chronic idiopathic myelofibrosis
- Myelofibrosis (idiopathic) (with myeloid metaplasia)
- Myelosclerosis (megakaryocytic) with myeloid metaplasia
- Secondary myelofibrosis in myeloproliferative disease
Type 1 Excludes
- acute myelofibrosis C94.4
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Myelofibrosis - D75.81
- with myeloid metaplasia - D47.4
- idiopathic (chronic) - D47.4
- in myeloproliferative disease - D47.4
- Myelosclerosis - D75.89
- with myeloid metaplasia - D47.4
- megakaryocytic - D47.4
- with myeloid metaplasia - D47.4
- Osteomyelofibrosis - D47.4
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Myelofibrosis
- with myeloid metaplasia
- Myelofibrosis
- idiopathic (chronic)
- Myelofibrosis
- secondary
- in myeloproliferative disease
- Myelosclerosis
- with myeloid metaplasia
- Myelosclerosis
- megakaryocytic
- Myelosclerosis
- megakaryocytic
- with myeloid metaplasia
- Osteomyelofibrosis
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Primary Myelofibrosis
a de novo myeloproliferation arising from an abnormal stem cell. it is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by cytokines arising from the abnormal clone.Cytokines
non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. they differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. they generally act locally in a paracrine or autocrine rather than endocrine manner.
Patient EducationClinical
Bone Marrow Diseases
Bone marrow is the spongy tissue inside some of your bones, such as your hip and thigh bones. It contains stem cells. The stem cells can develop into the red blood cells that carry oxygen through your body, the white blood cells that fight infections, and the platelets that help with blood clotting.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert D47.4 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About D47.4Overview
Is D47.4 a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report osteomyelofibrosis on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does D47.4 group to?
When osteomyelofibrosis is the principal diagnosis on an inpatient stay, it groups to MS-DRG 814, 815, 816, with relative weights from 0.6320 to 2.1267 depending on complications. Higher weights mean higher Medicare reimbursement.
What is the ICD-9 equivalent of D47.4?
Under the General Equivalence Mappings, osteomyelofibrosis converts to ICD-9-CM 289.89 (blood diseases NEC). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.
